AU675090B2 - The use of thrombin inhibitors for the inhibition of ocular fibrin formation - Google Patents

The use of thrombin inhibitors for the inhibition of ocular fibrin formation

Info

Publication number
AU675090B2
AU675090B2 AU52436/93A AU5243693A AU675090B2 AU 675090 B2 AU675090 B2 AU 675090B2 AU 52436/93 A AU52436/93 A AU 52436/93A AU 5243693 A AU5243693 A AU 5243693A AU 675090 B2 AU675090 B2 AU 675090B2
Authority
AU
Australia
Prior art keywords
inhibition
thrombin inhibitors
fibrin formation
ocular
ocular fibrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU52436/93A
Other versions
AU5243693A (en
Inventor
Eric-Paul Paques
Jurgen Romisch
Eckhard Schuler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU5243693A publication Critical patent/AU5243693A/en
Application granted granted Critical
Publication of AU675090B2 publication Critical patent/AU675090B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
AU52436/93A 1992-12-17 1993-12-15 The use of thrombin inhibitors for the inhibition of ocular fibrin formation Ceased AU675090B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4242655A DE4242655A1 (en) 1992-12-17 1992-12-17 Use of thrombin inhibitors to inhibit ocular fibrin formation
DE4242655 1992-12-17

Publications (2)

Publication Number Publication Date
AU5243693A AU5243693A (en) 1994-06-30
AU675090B2 true AU675090B2 (en) 1997-01-23

Family

ID=6475561

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52436/93A Ceased AU675090B2 (en) 1992-12-17 1993-12-15 The use of thrombin inhibitors for the inhibition of ocular fibrin formation

Country Status (7)

Country Link
EP (1) EP0603112A1 (en)
JP (1) JPH06228006A (en)
KR (1) KR940013532A (en)
AU (1) AU675090B2 (en)
CA (1) CA2111644A1 (en)
DE (1) DE4242655A1 (en)
NO (2) NO934653L (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510369A (en) * 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
US5629324A (en) * 1995-04-10 1997-05-13 Merck & Co., Inc. Thrombin inhibitors
US5798377A (en) * 1996-10-21 1998-08-25 Merck & Co., Inc. Thrombin inhibitors
EP1265639A1 (en) * 2000-03-20 2002-12-18 Knoll GmbH The use of anticoagulant agents in the extracorporeal treatment of blood
US6528503B2 (en) 2000-12-18 2003-03-04 Merck & Co., Inc. Thrombin inhibitors
WO2002050056A1 (en) 2000-12-18 2002-06-27 Merck & Co., Inc. Benzylamine derivatives and their use as thrombin inhibitors
US7144899B2 (en) 2001-02-09 2006-12-05 Merck & Co., Inc. Thrombin inhibitors
US7084134B2 (en) 2002-05-02 2006-08-01 Merk & Co., Inc. Thrombin inhibitors

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0193330A2 (en) * 1985-02-16 1986-09-03 MERCK PATENT GmbH Hyaluronidase, isolation and pharmaceutical use thereof, and pharmaceutical and veterinary formulations containing it

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8203887D0 (en) * 1982-06-23 1982-06-23 Kabivitrum Ab NEW TROMBIN INHIBITIVE ASSOCIATIONS
DE3445532A1 (en) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn HIRUDIN-PA, DESULFATOHIRUDINE-PA, METHOD FOR PRODUCTION AND PHARMACEUTICAL AGENTS THAT CONTAIN THESE ACTIVE SUBSTANCES
PT84170B (en) * 1986-01-24 1989-03-30 Sanofi Sa N-ALPHA-ARIL-SULFONYLAMINOACYL D-AMIDINEFENYL-ALANINAMID D NON-SUBSTITUTED DERIVATIVES PROCESS FOR THE PREPARATION OF N ALPHA-SUBSTITUTED DERIVATIVES
NL8902454A (en) * 1989-10-03 1991-05-01 Stichting Centraal Lab MUTANTS OF THE HUMANE PLASMINOGENIC ACTIVATOR INHIBITOR 1 (PAI-1), THEIR PREPARATION AND USE, AND RECOMBINANT POLYNUCLEOTIDES INCLUDING GENETIC INFORMATION CODING FOR THESE MUTANTS.
TW201303B (en) * 1990-07-05 1993-03-01 Hoffmann La Roche
DE4111394A1 (en) * 1991-04-09 1992-10-15 Behringwerke Ag AMIDINOPHENYLALANINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THE USE THEREOF AND MEANS THEREOF

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0193330A2 (en) * 1985-02-16 1986-09-03 MERCK PATENT GmbH Hyaluronidase, isolation and pharmaceutical use thereof, and pharmaceutical and veterinary formulations containing it

Also Published As

Publication number Publication date
DE4242655A1 (en) 1994-06-23
KR940013532A (en) 1994-07-15
AU5243693A (en) 1994-06-30
EP0603112A1 (en) 1994-06-22
JPH06228006A (en) 1994-08-16
NO934653L (en) 1994-06-20
NO934653D0 (en) 1993-12-16
CA2111644A1 (en) 1994-06-18

Similar Documents

Publication Publication Date Title
AU5208193A (en) Guanidinyl-substituted heterocyclic thrombin inhibitors
AU7145294A (en) Heterocyclic thrombin inhibitors
AU4267293A (en) Use of MMP inhibitors
AU5533094A (en) Enzyme inhibitors
HU9500685D0 (en) Sulfonamide inhibitors of hiv-aspartyl protease
AU4019289A (en) Hiv protease inhibitors useful for the treatment of aids
PL314838A1 (en) Inhibitors of bp-iv-serine protease
ZA939285B (en) Inhibitors of aspartyl protease
AU3832895A (en) Thrombin inhibitors
AU1677092A (en) Tetrahydroxyalkane derivatives as inhibitors of hiv aspartyl protease
HU9503170D0 (en) Hiv protease inhibitors useful for the treatment of aids
AU627937B2 (en) Inhibitors of retroviral proteases
AU1954392A (en) Inhibitors of hiv protease useful for the treatment of aids
AU3107795A (en) Inhibitors of the benzamidine type
AU3708093A (en) Processes for the preparation of amylase inhibitor
AU6183794A (en) Guanidinyl- or amidinyl-substituted methylamino heterocyclic thrombin inhibitors
AU5069993A (en) Retroviral protease inhibitors
AU2251892A (en) Inhibitors of picornavirus proteases
AU6183494A (en) Guanidinyl- or amidinyl-substituted heterocyclic thrombin inhibitors
AU8320691A (en) Inhibitors of retroviral proteases
AU4135493A (en) Inhibitors of HIV protease useful for the treatment of AIDS
AU5252993A (en) Inhibitors of HIV protease useful for the treatment of AIDS
AU5323694A (en) 17beta -carboxanilides of 4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors
AU675090B2 (en) The use of thrombin inhibitors for the inhibition of ocular fibrin formation
AU2277597A (en) New inhibitors of sh2-mediated processes

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired